| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
34,525 |
28,826 |
$819K |
| 87428 |
|
22,531 |
19,134 |
$558K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
8,880 |
7,911 |
$531K |
| 80050 |
General health panel |
14,652 |
12,840 |
$501K |
| 36415 |
Collection of venous blood by venipuncture |
105,887 |
87,206 |
$473K |
| 80053 |
Comprehensive metabolic panel |
43,562 |
37,530 |
$299K |
| 80061 |
Lipid panel |
33,223 |
28,695 |
$283K |
| 87631 |
|
3,359 |
2,891 |
$276K |
| 84443 |
Thyroid stimulating hormone (TSH) |
22,506 |
19,555 |
$211K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
37,435 |
32,634 |
$211K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
11,670 |
9,914 |
$194K |
| 87800 |
|
5,738 |
4,992 |
$178K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
27,417 |
23,816 |
$174K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
7,219 |
5,946 |
$162K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
7,212 |
5,944 |
$161K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
3,560 |
3,051 |
$124K |
| 81003 |
|
55,757 |
36,796 |
$121K |
| 86780 |
|
10,277 |
8,978 |
$116K |
| 81025 |
|
18,235 |
15,823 |
$109K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
595 |
533 |
$108K |
| 86803 |
|
8,925 |
7,880 |
$106K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
5,315 |
4,779 |
$92K |
| 87340 |
|
8,446 |
7,469 |
$87K |
| 87653 |
|
2,985 |
2,655 |
$76K |
| 84439 |
|
8,966 |
7,728 |
$72K |
| 80074 |
|
1,675 |
1,472 |
$63K |
| 82607 |
|
5,941 |
4,947 |
$60K |
| 83655 |
|
6,319 |
5,681 |
$58K |
| 87807 |
|
5,433 |
4,600 |
$52K |
| 86762 |
|
4,207 |
3,713 |
$47K |
| 82043 |
|
6,920 |
5,941 |
$35K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
5,502 |
4,777 |
$32K |
| 82570 |
|
7,026 |
5,928 |
$32K |
| 86709 |
|
1,476 |
1,363 |
$31K |
| 84702 |
|
2,512 |
1,557 |
$31K |
| 85027 |
|
8,034 |
6,337 |
$29K |
| 80305 |
|
3,212 |
2,448 |
$27K |
| 83550 |
|
4,141 |
3,596 |
$26K |
| 82728 |
|
2,831 |
2,436 |
$26K |
| 83540 |
|
4,629 |
4,035 |
$24K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
740 |
634 |
$23K |
| 87486 |
|
728 |
626 |
$22K |
| 84153 |
|
1,816 |
1,608 |
$22K |
| 87581 |
|
728 |
625 |
$22K |
| 83735 |
|
3,753 |
3,197 |
$19K |
| G0433 |
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening |
2,692 |
2,508 |
$18K |
| 85018 |
|
8,548 |
7,625 |
$18K |
| 87081 |
|
2,981 |
2,649 |
$17K |
| G0435 |
Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening |
1,849 |
1,702 |
$17K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
486 |
402 |
$14K |
| 84146 |
|
914 |
769 |
$14K |
| 82950 |
|
3,423 |
3,049 |
$14K |
| 87660 |
|
907 |
838 |
$12K |
| 87480 |
|
884 |
818 |
$12K |
| 87510 |
|
884 |
817 |
$11K |
| 87634 |
|
242 |
220 |
$11K |
| 83001 |
|
892 |
731 |
$10K |
| 36416 |
|
10,305 |
8,550 |
$10K |
| 82746 |
|
915 |
772 |
$9K |
| 82274 |
|
537 |
487 |
$9K |
| 85610 |
|
3,054 |
1,866 |
$8K |
| 83690 |
|
1,341 |
1,088 |
$7K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
207 |
197 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
509 |
486 |
$7K |
| 86777 |
|
519 |
478 |
$6K |
| 85652 |
|
1,695 |
1,449 |
$6K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,181 |
1,028 |
$6K |
| 83002 |
|
442 |
377 |
$5K |
| 82150 |
|
1,140 |
911 |
$5K |
| 84550 |
|
1,165 |
943 |
$5K |
| 84436 |
|
955 |
771 |
$4K |
| 86430 |
|
553 |
457 |
$4K |
| 86706 |
|
415 |
367 |
$3K |
| 80076 |
|
349 |
307 |
$3K |
| 82947 |
|
862 |
729 |
$3K |
| 84479 |
|
673 |
543 |
$2K |
| 82951 |
|
282 |
230 |
$2K |
| 84460 |
|
199 |
190 |
$2K |
| 86708 |
|
93 |
87 |
$2K |
| 86580 |
|
390 |
314 |
$1K |
| 84156 |
|
538 |
427 |
$1K |
| 80164 |
|
70 |
66 |
$1K |
| 86318 |
|
88 |
77 |
$1K |
| 86308 |
|
355 |
301 |
$1K |
| 81001 |
|
199 |
184 |
$1K |
| 87529 |
|
49 |
40 |
$1K |
| 84450 |
|
117 |
111 |
$967.04 |
| 84703 |
|
113 |
106 |
$847.45 |
| 82977 |
|
199 |
157 |
$807.20 |
| 88175 |
Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer |
78 |
69 |
$772.84 |
| 82952 |
|
226 |
195 |
$583.33 |
| 87186 |
|
134 |
109 |
$499.58 |
| 86703 |
|
56 |
49 |
$408.63 |
| 86850 |
|
76 |
71 |
$345.44 |
| 88720 |
|
72 |
38 |
$310.23 |
| 82550 |
|
13 |
13 |
$267.77 |
| 84132 |
|
29 |
28 |
$183.21 |
| G0328 |
Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous |
127 |
124 |
$134.98 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
18 |
17 |
$121.06 |
| 86900 |
|
76 |
71 |
$110.04 |
| 86901 |
|
72 |
68 |
$92.83 |
| 84100 |
|
29 |
28 |
$44.98 |
| 80069 |
|
14 |
12 |
$41.63 |
| 3044F |
|
17 |
13 |
$0.02 |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
100 |
89 |
$0.00 |